Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 473 - Heterocyclic compounds containing purine ring systems
Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
11/2012
11/01/2012CA2826197A1 Pyrrolotriazinone derivatives as pi3k inhibitors
10/2012
10/31/2012EP2518071A1 Imidazopyridine derivatives as PI3K inhibitors
10/31/2012EP2518070A1 Pyrrolotriazinone derivatives as PI3K inhibitors
10/30/2012US8299038 Methods and compositions for treating hepatitis C virus
10/25/2012US20120270842 Inhibitors of Diacylglycerol O-Acyltransferase 1 (DGAT-1) and Uses Thereof
10/24/2012EP2513090A1 Compound suitable for the treatment of synucleopathies
10/24/2012CN102753553A 6-amino-2-{ [ (1s)-1-methylbutyl] oxy}-9-[5-(1-piperidinyl)-7,9-dihydro-8H-purin-8-one maleate
10/24/2012CN102753527A Cyclohexyl amide derivatives as crf receptor antagonists
10/24/2012CN102746304A Purinamine compound and preparation method thereof
10/24/2012CN102212065B Isonucleoside compound or ortho-phosphite derivative thereof and preparation method and application thereof
10/24/2012CN102002043B Method for synthesizing 6-methoxy group purine derivative in presence of 4-aminopyridine as catalyst
10/23/2012US8293682 Growth regulators for gramineous weeds
10/18/2012WO2012142029A2 Serms for the treatment of estrogen receptor-mediated disorders
10/18/2012US20120264769 Methanocarba adenosine derivatives and dendrimer conjugates thereof
10/18/2012US20120264706 Purine derivatives as adenosine a1 receptor agonists and methods of use thereof
10/17/2012EP2511283A1 N6-substituted adenosine derivatives, n6-substituted adenine derivatives and uses thereof
10/17/2012CN102741254A Process for preparing entecavir and its intermediates
10/17/2012CN102741253A Pi3k (delta) selective inhibitors
10/17/2012CN102732523A Aptamer for identifying zeatin through specifity, and screening method and application of aptamer
10/17/2012CN102731501A Method for refining and purifying adenine
10/16/2012US8288397 Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of TRPV1
10/16/2012US8288381 N-9 substituted purine compounds, compositions and methods of use
10/16/2012CA2563895C Disalt inhibitors of il-12 production
10/16/2012CA2554426C Agents for treating migraine
10/11/2012WO2012138896A1 Hsp90 inhibitors
10/11/2012WO2012138894A1 Hsp90 inhibitors
10/11/2012WO2012136492A1 Wnt pathway antagonists
10/11/2012US20120258950 PYRROLO[2,3-d]PYRIMIDINE TROPOMYSIN-RELATED KINASE INHIBITORS
10/11/2012US20120258927 Inhibitors of e1 activating enzymes
10/11/2012US20120258170 Pharmaceutical co-crystals of quercetin
10/11/2012CA2832530A1 Hsp90 inhibitors
10/11/2012CA2832305A1 Wnt pathway antagonists
10/11/2012CA2832099A1 Hsp90 inhibitors
10/10/2012EP2507241A1 Methanocarba adenosine derivatives and dendrimer conjugates thereof
10/10/2012CN102725284A Compound suitable for the treatment of synucleopathies
10/10/2012CN102718767A Method for synthesizing diacetylacyclovir
10/10/2012CN102718766A Method for preparing diacetylacyclovir with 7-bit diacetylacyclovir
10/10/2012CN102718765A Method for preparing and purifying Valganciclovir hydrochloride
10/10/2012CN102718764A Preparation method of 3-methyl-7-propylxanthine
10/10/2012CN101987847B Novel heterocyclic NF-kB inhibitors
10/10/2012CN101142194B Benzazole derivatives, compositions, and methods of use as b-secretase inhibitors
10/04/2012US20120252823 Adenosine receptor agonists, partial agonists, and antagonists
10/04/2012US20120252791 Heterocyclic GTP Cyclohydrolase 1 Inhibitors For the Treatment of Pain
10/04/2012US20120252783 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
10/04/2012US20120252782 Xanthine Derivatives, the Preparation Thereof and Their Use as Pharmaceutical Compositions
10/04/2012US20120251482 Use for improving 5-ht function and enos expression of kmups amine salts
10/03/2012EP2503890A1 Azabenzimidazoles as fatty acid synthase inhibitors
10/03/2012CN102712642A N-7 substituted purine and pyrazolopyrimidine compounds, compositions and methods of use
10/03/2012CN102711766A N-9-substituted purine compounds, compositions and methods of use
10/03/2012CN102702199A Method for preparing ganciclovir
10/03/2012CN102702198A Caffeine methylated mother liquor cleaning process and device thereof
10/03/2012CN102702147A Andrographolide analogue and application of andrographolide analogue to treatment
10/03/2012CN101851240B Ganciclovir purification process
10/03/2012CN101233135B Diaryl-purine, azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitors for treatment of HIV
10/02/2012CA2466477C A2b adenosine receptor antagonists
09/2012
09/27/2012US20120245169 Certain chemical entities, compositions and methods
09/27/2012US20120245140 N-containing heteroaryl derivatives as jak3 kinase inhibitors
09/27/2012US20120245138 N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl arylsulfonamides
09/27/2012US20120244211 Compositions And Methods For Treatment Of The Side-Effects Associated With Administration Of Cancer Chemotherapeutic Agents
09/26/2012EP2501709A2 2'-fluoro-6'-methylene carbocyclic nucleosides and methods of treating viral infections
09/25/2012US8273877 Substituted tetraazapentalenes
09/20/2012WO2012082436A3 Modulators of histone methyltransferase, and methods of use thereof
09/20/2012US20120238592 Use and Application of a Pharmaceutical Composition Containing a Mixture of Natural-Origin Heterocylcial Guanidine
09/20/2012US20120238566 Use of cell autophagy (type ii cell apoptosis) inhibitors
09/19/2012EP2499143A1 N-7 substituted purine and pyrazolopyrimidine compounds, compositions and methods of use
09/19/2012EP2499142A1 Substituted fused pyrimidine compounds, its preparation and uses thereof
09/19/2012EP2499126A1 Fused bicyclic pyridine and pyrazine derivatives as kinase inhibitors
09/19/2012CN102675355A Process for preparing the antiviral agent [1S-(1alpha,3 alpha,4beta)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one
09/19/2012CN102675317A Method for extracting a plurality of kinds of active ingredients from tea leaves simultaneously
09/19/2012CN102675316A Quinazoline purine derivative and application thereof in preparation of diabetes drugs
09/19/2012CN102675315A Substitutive benzene alkyl contained purine compounds and preparation method and application thereof
09/18/2012US8268839 Compounds
09/18/2012US8268838 Substituted purinyl-pyrazole derivatives and their use as potassium channel modulators
09/13/2012US20120232090 Arylpiperazine-containing purine derivatives and uses thereof
09/13/2012US20120232077 Selective antibacterials for clostridium difficile infections
09/13/2012US20120232073 Fused bicyclic pyrimidine derivatives and methods of use thereof
09/12/2012CN102666541A Derivatives of purine or deazapurine useful for the treatment of (inter alia) viral infections
09/12/2012CN102659785A 2-amino-6-aminomethylpurine compound and preparation method and application thereof
09/11/2012US8263601 Deuterium substituted xanthine derivatives
09/11/2012CA2445159C Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
09/06/2012US20120225869 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
09/06/2012US20120225812 Substituted fused pyrimidine compounds, its preparation and uses thereof
09/05/2012CN102656172A 8-oxodihydropurine derivative
09/04/2012US8258142 Substituted 8-[6-amino-3-pyridyl]xanthines
09/04/2012US8258141 Organic compounds
08/2012
08/30/2012US20120220586 Heterocyclic compounds and their uses
08/30/2012US20120220585 Heterocyclic compounds and their uses
08/30/2012US20120220576 Novel Heterocyclic Derivatives
08/29/2012EP2492264A2 Biaryl Heterocyclic Compounds And Methods Of Making And Using The Same
08/29/2012EP2491035A1 Derivatives of purine or deazapurine useful for the treatment of (inter alia) viral infections
08/29/2012EP2491025A1 Azaazulene compounds
08/29/2012EP2490692A1 Quinolinone-pyrazolone m1 receptor positive allosteric modulators
08/29/2012CN102649792A Combined preparation method for eritadenine and lentinan
08/29/2012CN101899045B 9-substituted-2-amino-6-guanidyl purine compounds as well as preparation method and application thereof
08/29/2012CN101516882B Selective antagonists of A2A adenosine receptors
08/28/2012US8252798 Purine compounds
08/28/2012US8252797 Heterocyclic compounds as adenosine receptor antagonist
08/28/2012US8252791 Purine compounds as cannabinoid receptor blockers
08/28/2012CA2671744C Compounds and compositions as protein kinase inhibitors
08/23/2012WO2012074249A3 Novel purinylpyridinylamino-2,4-difluorophenyl sulfonamide derivative, pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition with inhibitory activity against raf kinase, containing same as active ingredient
1 ... 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 ... 120